« Back
Home /
Carmofur

Carmofur

Item no.	TMO-T1307-200mg
Manufacturer	TargetMol
CASRN	61422-45-5
Amount	200 mg
Quantity options	100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 200 mg 500 mg 50 mg 5 mg
Category	Oncology Reagents & Chemicals Molecules By Organ Breast Cancer
Type	Molecules
Specific against	other
Purity	0,98
Smiles	CCCCCCNC(=O)n1cc(F)c(=O)[nH]c1=O
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	HCFU
Similar products	61422-45-5
Shipping Condition	Cool pack
Available
Manufacturer - Targets	SARS-CoV\|\|\|Nucleoside Antimetabolite/Analog\|\|\|DNA/RNA Synthesis\|\|\|Virus Protease
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	257.26
Description	Carmofur (HCFU) is a highly potent acid ceramidase inhibitor, used in the treatment of breast and colorectal cancer. Carmofur has been known to induce leukoencephalopathy.
Pathways	DNA Damage/DNA Repair\|\|\|Cell Cycle/Checkpoint\|\|\|Microbiology/Virology

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T1307-200mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 200 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question